Which COVID-19 vaccine should I get?

Should I try and get an mRNA vaccine? They are better than the others, aren’t they? If I show up at the clinic can I choose?

 These are some of the questions that we didn’t even know we would be so lucky to ask just three months ago. 

The speed at which multiple vaccines to choose from has come about is unprecedented. 

The first genome sequence of a previously unknown virus was published in early January 2020 and the Pfizer and Moderna mRNA vaccines, tested over the summer and fall of 2020, were approved for emergency use in early December. 

These are the quickest vaccines ever developed. Their very speed has raised a lot of questions around their safety. It is true that all previous vaccines have taken years to develop and the cumulative experience of their use over time is reassuring. 

Moderate reactions

Nevertheless the COVID-19 vaccines have been tested in very big trials. As a comparison, the widely used and “uncontroversial” Shingrix vaccine for prevention of shingles was tested in 32,000 participants prior to submission for approval in 2017. The total number of patients in COVID-19 vaccine trials that have reported results so far is 170,000 and growing rapidly. 

The safety results have been reassuring — both in the trial participants and now in millions of people worldwide who have been vaccinated and reported to national monitoring systems. 

Rates of severe side effects, mainly anaphylaxis, have been very rare — a handful in every million vaccinated — and the more common reactions such as arm pain, fever, fatigue and muscle aches have been over very quickly. 

The brief discomfort of COVID-19 vaccines seems to be greater than for the annual flu shot. This probably reflects a combination of both the “prime-boost” two-shot strategy to provoke maximum stimulation of the immune system; and the large group of vaccinees who were recently infected naturally with SARS-CoV-2 and already have a naturally primed immune system ready to react. Maybe the single-shot Johnson & Johnson vaccine will have fewer reactions?

Don’t compare
the numbers

There are now three vaccines available in the USA (Pfizer, Moderna and Johnson & Johnson) and several more globally, with more to come. 

Inevitable comparisons between the different vaccines, using their “headline” efficacy numbers, is a favorite media story at the moment. This has stimulated “vaccine shopping,” which has reached damaging levels in places like Germany, where the UK Astra-Zeneca vaccine sits un-used in warehouses whilst people wait, unprotected, for the Pfizer vaccine. 

The efficacy numbers attached to the two shots is responsible for this: 95% for Pfizer versus 62% for Astra-Zeneca. 

These numbers are a snapshot in time and can’t be compared with each other. 

Different vaccine trials

The Pfizer number was generated from a trial mainly in the USA, where most of the patients were recruited in the summer and fall of 2020. 

The Astra-Zeneca number was reported from a trial that included a substantial mixture of patients from the UK, South Africa and Brazil. 

The Pfizer and Moderna trials closely adhered to the three- or four-week interval between doses, whereas the Astra-Zeneca trial had a less strict timing. 

The different trials measured infection and symptoms in different ways at different time points. 

In more recent trials — for example the Johnson & Johnson and Novavax trials — there were large numbers of infections with new virus variants included as well. 

The efficacy result of each trial is reflective of the performance of the vaccine WITHIN that trial compared with a placebo — but not comparable OUTSIDE of the trial with the other vaccines.

Real-world results

To emphasize this, we have recent large-scale program results from the Scottish National Health Service. 

The Astra-Zeneca vaccine has been 94% effective in reducing hospitalizations so far compared with the Pfizer vaccine, which has been 85% effective. 

This reversal of efficacy rankings in a real-world observation simply emphasizes that both vaccines are great. 

The most important number of all to remember is that in the thousands and thousands of trial participants who received any of the vaccines there were no COVID deaths and almost no hospitalizations for COVID.

So when you have finally managed to find your vaccine appointment after refreshing the sign-up page a hundred times and been booked four weeks hence, don’t worry about which vaccine you will get. Just pick the one with the smallest needle.

 

James Shepherd, MD PhD, lives in Sharon, Conn., and is an Infectious Disease physician and epidemiologist who is on the faculty of the Yale University School of Medicine.

The views expressed here are not necessarily those of The Millerton News and The News does not support or oppose candidates for public office.

Latest News

Amenia board honors employees for service

Long-term town employees were recognized at the Town Board meeting on Thursday, June 12. Honorees pictured with Town Supervisor Leo Blackman, were Judy Carlson, Office Manager at the Town Garage, center, for her 35 years of service to the town and Megan Chamberlin, current Highway Superintendent, for 20 years.

Leila Hawken

AMENIA — Acknowledging the many years of service accumulated by town employees, the Town Board paused to honor that service at its meeting on Thursday, June 12.

“Thank you for making a difference,” said Town Supervisor Leo Blackman in recognizing Judy Carlson, Office Manager at the town garage, for her 35 years of service.

Keep ReadingShow less
Historic marker dedicated at Amenia Union Cemetery

In anticipation of the celebration of the 250th anniversary of the start of the American Revolution in 2026, new historic markers are appearing at each of the local cemeteries where Revolutionary War veterans are buried. Unveiling the new marker at Amenia Union Cemetery on Saturday, June 21, were left to right, Town Historian Betsy Strauss, Jim Middlebrook representing the regional chapter of the Sons of the American Revolution, and Gail Seymour, President of the Union Cemetery Association.

Photo by Leila Hawken

AMENIA — One by one, new historic markers are appearing at local cemeteries where Revolutionary War dead are buried. On Saturday, June 21, community members gathered to see a new marker unveiled at Amenia Union Cemetery on Leedsville Road.

A tent provided welcome shade for the attendees and refreshments as about 30 residents gathered for the unveiling and to share stories of local history with one another.

Keep ReadingShow less
Millerton Street Fair celebration June 28

Bee Bee the clown, face painters and a community wide scavenger hunt are among the activities planned for the Millerton Street Fair in Downtown Millerton on Saturday, June 28.

Photo by Aly Morrissey

MILLERTON — The Millerton News, in partnership with the North East Community Center (NECC) and the Millerton Business Alliance, is hosting its first Street Fair on Saturday in a celebration of the town.

Rain or shine from 10 a.m. to 2 p.m, the fair will bring together local nonprofits and businesses, with live music, entertainment, kids’ activities, local eats, and family fun in Veterans Park, in front of the Millerton Inn, and beyond.

Keep ReadingShow less
Millbrook Historical Society announces summer Quaker lecture series

The Nine Partners Road Quaker Meetinghouse, built in 1780, will be the site of two summer lectures sponsored by the Millbrook Historical Society.

Photo by Leila Hawken

MILLBROOK — Long in the planning, the Millbrook Historical Society has announced that it is sponsoring two lectures in observance of the 250th anniversary of the American Revolution. Both lectures relating to Quaker history are to be held in the historic Quaker Meeting House on Nine Partners Road.

For the first talk, scheduled for Sunday, June 29, at 2 p.m., the historical society has invited Sarah Gronningsater, Professor of History at the University of Pennsylvania, to talk on “Quakers, Anti-slavery, and the American Revolution.” The topic will explore the role that New York’s Quakers, especially in the Hudson Valley, played in the rise of the anti-slavery movement that followed the American Revolution.

Keep ReadingShow less